Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Analysis of Patients With Neovascular Age-Related Macular Degeneration Responsive to Ranibizumab But Resistant to Aflibercept

NCT02291887 is registered in ClinicalTrials.gov with Associated Retinal Consultants, Michigan as lead sponsor.

NCT NCT02291887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02291887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Analysis of Patients With Neovascular Age-Related Macular Degeneration Responsive to Ranibizumab But Resistant to Aflibercept
Lead sponsor
Associated Retinal Consultants, Michigan
Phase
Observational
Overall status
Completed
Start date
December 22, 2014
Completion date
July 1, 2015
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration